CUPR
Cuprina Holdings (Cayman) Limited
Healthcare — Medical Instruments & Supplies
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Price History
Fundamentals
| Market Cap | $7.83M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-1.42 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 267.40% |
| ROE | -1569.06% |
| Debt/Equity | 67.52 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 24.9 |
| Beta | - |
| SMA 20 | $4.03 |
| SMA 40 | $4.25 |
| 52-Week High | $76.00 |
| 52-Week Low | $1.76 |
| 50-Day Avg | $3.89 |
| 200-Day Avg | $3.97 |
| Avg Volume | $3.12M |
| Volume | 774.6K |
Performance Analysis
BULLISHCUPR shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Aug 01, 2026 04:12 UTC
Back to Screener Export Report